Quoin Pharmaceuticals Ltd. Rightofuse Assets
Quoin Pharmaceuticals Ltd. (QNRX) had Rightofuse Assets of ILS 1.51 million as of 2020-12-31, per its 20-F filed 2021-03-29.
Discontinued › Notes
ifrs-full:RightofuseAssets · last filed 2021-03-29
- 2020-12-31: Rightofuse Assets 1.51M ILS.
- 2020-06-30: Rightofuse Assets 908.00K ILS.
- 2019-12-31: Rightofuse Assets 1.47M ILS; Rightofuse Assets as first filed 1.03M ILS.
- 2019-06-30: Rightofuse Assets 1.30M ILS.
| Period end | Rightofuse Assets | Rightofuse Assets as first filed |
|---|---|---|
| 2020-12-31 | 1.51M ILS 20-F · filed 2021-03-29 | |
| 2020-06-30 | 908.00K ILS 6-K/A · filed 2021-02-11 | |
| 2019-12-31 | 1.47M ILS 20-F · filed 2021-03-29 | 1.03M ILS 6-K/A · filed 2021-02-11 |
| 2019-06-30 | 1.30M ILS 6-K · filed 2019-08-13 | |
| 2018-12-31 | 1.61M ILS 20-F · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |